WB
NRIX icon

WesBanco Bank’s Nurix Therapeutics NRIX Stock Holding History

WesBanco Bank’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Buy
+62,700
New +$1.07M 0.04% 319

Other funds holding NRIX

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WFA
WestHill Financial Advisors San Rafael, California $587M AUM 20.13% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

WesBanco Bank's NRIX Position: Q2 2026 in Review

WesBanco Bank opened a new position in Nurix Therapeutics (NRIX) in Q2 2026: 62,700 shares worth $1.52M. The stake represents 0.04% of the portfolio and ranks #319 among its holdings.

27 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • WesBanco Bank held 62,700 shares of Nurix Therapeutics worth $1.52M as of Q2 2026.
  • Nurix Therapeutics was a new WesBanco Bank position in Q2 2026.
  • Nurix Therapeutics made up 0.04% of WesBanco Bank's portfolio in Q2 2026, its #319 holding.
  • 27 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.